| INTRODUC TI ON
Extracorporeal photopheresis (ECP) is a therapy performed on two consecutive days, where plasma and leukocytes are separated extracorporally from the blood of the patient, incubated with the photo- 
| PATIENTS AND ME THODS

| RE SULTS AND D ISCUSS I ON
To our knowledge, this is the first attempt to examine the influence of ECP on serum vitamin D. What was novel in our study as compared to previous studies investigating the impact of UVA on vitamin D is that the skin of the patients was not irradiated, but rather the leukocytes and plasma of the patients were incubated with 8-MOP and then irradiated with UVA. We aimed at investigating a potential degrading effect of UVA on vitamin D directly.
For both 1,25VitD and 25VitD, a significant decrease in serum levels could be illustrated from TP1 to TP2 (1,25VitD: 44.64-39.82 pg/mL, P = 0.005; 25VitD: 45.14-41.42 nmol/L, P = 0.029) ( Figure 1A, B) . This could reflect a degrading effect of vitamin D due to ECP and could thus be due to 8-MOP and/or UVA. In order to exclude that this effect was related solely to a possible diluting effect caused by infusion of 500 mL of physiologic salt solution, which patients receive during ECP procedure, 1,25VitD and 25VitD serum levels were compared between TP1 and TP3. As we could observe the tendency of falling vitamin D serum levels also between TP1 and TP3 (1,25VitD: P = 0.229; 25VitD: P = 0.109) ( Figure 1A , B), we conclude that the decrease of 1,25VitD and 25VitD after ECP is very likely not solely due to dilution. The lack of significance in the decreases from the 1st to the 3rd time point may be the result of the small number of patients studied (Table 1) .
Patients, who had received more than six cycles of photopheresis before the beginning of the study (n = 6), were compared to patients, who had received less than six cycles (n = 3). The average serum levels of 25VitD were lower in the group with more than six cycles (TP1: 38.55 nmol/L vs 58.33 nmol/L, P = 0.18) ( Figure 1C ).
This could indicate a long-term effect of ECP on vitamin D although potential sun avoidance by patients treated with ECP could not be ruled out as a bias.
The mean PTH levels significantly increased from TP1 to TP2
(49.84-74.52 pg/mL, P = 0.042). Examining patients with either heparin (n = 9) or ACD (n = 2) as anticoagulation separately, the increase was more notable in the ACD group (heparin: 45.54-58.87 pg/mL, P = 0.17 vs ACD: 69.15-144.95 pg/mL, P = 0.063) ( Figure 1D ). This could be explained by the fact that ACD binds calcium ions and thereby may cause a mild hypocalcemia. 5 Consequently, the parathyroid secretes PTH to elevate plasma calcium. This is of particular interest concerning future studies examining the influence of ECP on 1,25VitD as a rise in PTH could subsequently cause a rise in 1,25VitD by activating renal 1-alpha-hydroxylase. This rise could potentially attenuate a decrease of 1,25VitD caused by ECP.
In conclusion and based on this first observation, it might be advisable to monitor vitamin D levels in patients receiving ECP therapy.
In particular, if the therapy is pursued over a long period, a considerable vitamin D deficiency could be the result and thus, a substitution of vitamin D might be indicated. In addition, our data might indirectly indicate a vitamin D degrading effect of UVA since ECP is a perfect model to study a potential degrading effect of vitamin D as the skin is taken out as a factor and UVA directly meets the plasma and leukocytes.
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